Medicare Group Q.P.S.C. (QSE:MCGS)
Qatar · Delayed Price · Currency is QAR | Market Cap | 1.57B -5.4% |
| Revenue (ttm) | 484.21M -7.4% |
| Net Income | 85.88M -4.6% |
| EPS | 0.31 -4.6% |
| Shares Out | 281.44M |
| PE Ratio | 18.33 |
| Forward PE | 13.64 |
| Dividend | 0.22 (3.94%) |
| Ex-Dividend Date | Apr 1, 2026 |
| Volume | 231,097 |
| Open | 5.59 |
| Previous Close | 5.59 |
| Day's Range | 5.59 - 5.59 |
| 52-Week Range | 4.81 - 7.21 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 18, 2026 |
About Medicare Group Q.P.S.C.
Medicare Group Q.P.S.C. operates hospital and promotes medical services in Qatar. The company provides medical services through hospitals and engages in operating clinics. It also offers medical and therapeutic care services. The company was formerly known as Al Ahli Specialized Hospital Company Q.S.C. The company was founded in 1995 and is based in Doha, Qatar. [Read more]
Financial Performance
In 2025, Medicare Group Q.P.S.C.'s revenue was 502.60 million, a decrease of -3.99% compared to the previous year's 523.49 million. Earnings were 76.01 million, an increase of 26.57%.
Financial StatementsNews
Ro Khanna calls for Medicare for All vote despite Hakeem Jeffries not supporting it: Full interview
Rep. Ro Khanna (D-Calif.) tells Meet the Press that Congress should hold a vote on Medicare for All if Democrats regain the majority, arguing that most House Democrats would back the policy despite Ho...
Medicare Launched a New Program Last Month That Could Lead to Big Savings for Seniors
This could be just what you need to improve your health and your finances.
‘My head hit the driver’s window’: A teenager T-boned our car. Will Medicare pay my hospital bills?
“My car was nearly 20 years old, and I only carried liability and uninsured motorist coverage, not collision coverage.”
Medicare is one of America’s greatest successes — and a fiscal time bomb
Medicare's Hospital Insurance trust fund faces depletion by 2033, triggering automatic cuts to provider payments that could devastate rural hospitals.
Medicare is about to change a drug program that held down the cost of premiums. Here’s what to know.
Experts say this could mean that more seniors will switch to Medicare Advantage plans
After Democrats' shake-up, Collins faces toss-up against Platner replacement in must-win Senate race
Susan Collins faces a fierce challenge from progressive Troy Jackson, who backs Medicare for All and abolishing ICE, in a toss-up Maine Senate race.
FBI nabs alleged $547M Medicare fraud fugitive overseas, third capture from 'Most Wanted Fraudsters' list
Khalid Ahmed Satary allegedly billed Medicare $547 million for unnecessary genetic tests on elderly patients before fleeing the country in 2022.
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
(RTTNews) - Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft reje...
All Eyes Are on Social Security's Financial Woes. But Medicare Is in Trouble, Too.
This could be a huge blow to many seniors' budgets.
Medicare Launches GLP-1 Bridge Program for Weight Loss Drugs
Medicare Launches GLP-1 Bridge Program for Weight Loss Drugs
Medicare Expands Coverage for GLP-1 Weight Loss Drugs, Retailers Step In
Medicare Expands Coverage for GLP-1 Weight Loss Drugs, Retailers Step In
Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an important role for patients.
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO)
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO)
Medicare Launches GLP-1 Bridge Program for Weight Loss Medications
Medicare Launches GLP-1 Bridge Program for Weight Loss Medications
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.
Who qualifies for Medicare's new $50 weight-loss drug program and what are the concerns?
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65 and older or with disabilit...
Medicare Expands Coverage for GLP-1 Weight Loss Drugs Boosting Novo Nordisk (NVO)
Medicare Expands Coverage for GLP-1 Weight Loss Drugs Boosting Novo Nordisk (NVO)
Medicare Launches GLP-1 Bridge Program for Obesity Treatment
Medicare Launches GLP-1 Bridge Program for Obesity Treatment
Medicare will start covering obesity drugs for the first time. Here's what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
Medicare's New GLP-1 Bridge Program Boosts Access to Eli Lilly's (LLY) Weight Loss Drugs
Medicare's New GLP-1 Bridge Program Boosts Access to Eli Lilly's (LLY) Weight Loss Drugs
Medicare to launch GLP-1s for $50: Here's what to know
CNBC’s Angelica Peebles reports on the latest news.
Millions of older Americans will soon have Medicare access to GLP-1s for weight loss. Here’s what they need to know.
Starting July 1, Medicare beneficiaries will have access to weight-loss drugs for the first time. There are some unique factors they should consider.
Social Security’s woes are well known, but Medicare is also facing a fiscal crisis — in just 7 years
Medicare Part A, which pays for inpatient hospital stays, would see an 11% payment cut.
Eli Lilly CEO: Obesity-care should be healthcare
At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Lilly CEO Dave Ricks to discuss what his expectations are for insurance coverage of GLP-1s and Me...